WS
WINT

Wedbush Securities’s Windtree Therapeutics Inc WINT Stock Holding History

Wedbush Securities’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10,784
Closed -$12K – 899
2017
Q1 		$12K Hold
10,784
– – ﹤0.01% 832
2016
Q4 		$13K Hold
10,784
– – ﹤0.01% 810
2016
Q3 		$28K Hold
10,784
– – ﹤0.01% 808
2016
Q2 		$21K Hold
10,784
– – ﹤0.01% 762
2016
Q1 		$18K Sell
10,784
-2
-0% -$4 ﹤0.01% 733
2015
Q4 		$32K Buy
10,786
+8,229
+322% +$33.8K 0.01% 698
2015
Q3 		$11K Buy
+2,557
New +$16.9K ﹤0.01% 710
2014
Q3 		– Sell
-874
Closed -$22K – 734
2014
Q2 		$22K Buy
+874
New +$22.3K ﹤0.01% 650
2014
Q1 		– Sell
-1,143
Closed -$36K – 662
2013
Q4 		$36K Sell
1,143
-423
-27% -$13.2K 0.01% 570
2013
Q3 		$43K Buy
+1,566
New +$38K 0.01% 550

Other funds holding WINT

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Wedbush Securities's WINT Position: Q2 2017 in Review

Wedbush Securities sold out of Windtree Therapeutics Inc (WINT) in Q2 2017, closing a stake of 10,784 shares — an estimated $12K sold.

Wedbush Securities first reported a position in WINT in Q3 2013 and held it in 10 quarters. The position peaked at $43K in Q3 2013. 3 funds tracked by Wall St. Rank hold WINT as of Q2 2017.

  • Wedbush Securities reported no remaining Windtree Therapeutics Inc position as of Q2 2017 after selling out during the quarter.
  • Wedbush Securities sold 10,784 Windtree Therapeutics Inc shares in Q2 2017, an estimated $12K.
  • Wedbush Securities first reported a position in Windtree Therapeutics Inc in Q3 2013 and held it in 10 quarters.
  • Wedbush Securities's Windtree Therapeutics Inc position peaked at $43K in Q3 2013.
  • 3 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2017.

Based on Wedbush Securities's 13F filing for Q2 2017, filed 2 Aug 2017.